Contact

The Regulation and Prequalification Department (RPQ) works in accordance with a Quality Management System (QMS) to ensure the quality of its processes and process outcomes. The structure of the QMS aligns with that recommended in ISO9001:2015. At the top of the QMS’s pyramid of documents sits the Quality Policy that identifies the quality objectives. The Quality Manual comes underneath the Policy and provides guidance on how processes are conducted to ensure quality process outcomes are achieved.

Medical product alerts

Publications

WHO’s work in the area of access and regulation is guided by the WHO 14th General Programme of Work...

The World Health Organization (WHO) Department of Regulation and Prequalification plays a unique role in the global health ecosystem through providing...

The World Health Organization (WHO) Department of Regulation and Prequalification plays a unique role in the global health ecosystem through providing...

The World Health Organization (WHO) Department of Regulation and Prequalification holds a unique role in the global health ecosystem. RPQ provides essential...

An effective regulatory system plays a critical role in ensuring the quality of health products, spanning from their development in the laboratory to their...

Department of regulation and prequalification, Strategic Action Plan 2025-2028

WHO’s Department of Regulation and Prequalification strategic action plan (2025–2028) sets out the five strategic priorities that will enable...

Delivering Quality-Assured medical products for all - 2019–2023

WHO’s 2019–2023 Plan to help build effective and efficient regulatory systems is designed to assist national regulators to deliver regulation that...

Roadmap for access to medicines, vaccines and health product 2019-2023: comprehensive support for access to medicines, vaccines and other health products

Equitable access to health products is a global priority, and the availability, accessibility, acceptability, and affordability of health products of...

Regulation and Prequalification update

The Regulation and Prequalification update in Arabic, Chinese, French, Spanish and Russian are also available from the links below.

Our Team

Mr Deusdedit Mubangizi

Director

Telephone: +41 22 791 1864

Email: mubangizid@who.int

Mrs. Irena Prat

Team lead - In Vitro Diagnostics Assessment

Telephone: +41 22 791 3927

Email: prati@who.int

Dr Samvel Azatyan

Team lead - Regulatory Convergence and Networks

Telephone: +41 22 791 1506

Email: azatyans@who.int

Miss Carmen A. Rodriguez Hernandez

Team lead - Vaccines & Immunization Devices Assessment

Telephone: +41 22 791 4362

Email: rodriguezhernandezc@who.int

Mr Hiiti Baran Sillo

Unit Head - Regulation and Safety

Telephone: +41 22 791 2486

Email: silloh@who.int

Dr Matthias Mario Stahl

Team lead - Medicines Assessment

Telephone: +41 22 791 3717

Email: stahlm@who.int

Dr Jicui Dong

Unit Head - Product Policies, Access and Manufacturing support

Dr Shanthi Pal

Team Lead, Pharmacovigilance

Telephone: +41 22 791 1318

Email: pals@who.int

Dr Khadem Broojerdi Alireza

Unit Head - Prequalification

Telephone: +41 22 791 4637

Email: khadembroojerdia@who.int

Mrs Marie Valentin

Team Lead, Facilitated Product Introduction

Email: valentinm@who.int

Mr Rutendo Kuwana

Team Lead, Incidents and SF

Email: kuwanaru@who.int

Publications

All →
WHO Drug Information - Volume 40, No. 1

The First issue of volume 40 for 2026 includes:Consultation Documents: - Dapsone (dapsonum)- Dapsone Tablets (dapsoni compressi)International Nonproprietary...

WHO Drug Information - Volume 39, No. 4

The Fourth issue of volume 39 for 2025 includes:Pharmaceutical News- Thin-Layer Chromatography: A Valuable Tool in the Fight Against Substandard/Falsified...

Advancing institutional compliance and continuous improvement in vaccine manufacturing: Virtual training marathon kit 2024

The 2024 Virtual cGMP Training Marathon represented a crucial step towards strengthening local vaccine manufacturing capabilities in LMICs. This annual...

Driving quality across the product lifecycle for medicines, vaccines, biotherapeutic products, and in vitro diagnostics: Week of Quality 2024 training kit

Ensuring quality of the health product ensures its safety and efficacy. Manufacturers in low- and middle-income countries (LMICs) face challenges to...